Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retrospective 3-year comparison of nevirapine vs efavirenz (2NN follow-up)
2004-000623-16Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nevirapine and efavirenz in human immunodeficiency virus infection (HIV) (4 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Treatment failure at 144 weeks (nevirapine vs efavirenz) and Treatment failure at 144 weeks (four treatment arms). Started Feb 2005; status: completed.
02
Drugs
nevirapineefavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2004-000623-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000623-16.